help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2006-0367
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sainsbury, A.
Right arrow Articles by Herzog, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sainsbury, A.
Right arrow Articles by Herzog, H.
Molecular Endocrinology 21 (7): 1722-1735
Copyright © 2007 by The Endocrine Society

Dynorphin Knockout Reduces Fat Mass and Increases Weight Loss during Fasting in Mice

Amanda Sainsbury, Shu Lin, Keely McNamara, Katy Slack, Ronaldo Enriquez, Nicola J. Lee, Dana Boey, George A. Smythe, Christoph Schwarzer, Paul Baldock, Tim Karl, En-Ju D. Lin, Michelle Couzens and Herbert Herzog

Neuroscience Program (A.S., S.L., K.M., K.S., N.J.L., D.B., C.S., T.K., E.-J.D.L., M.C., H.H.) and Bone and Mineral Research Program (R.E., P.B.), Garvan Institute of Medical Research, St. Vincent’s Hospital, Darlinghurst, Sydney, New South Wales 2010, Australia; Bioanalytical Mass Spectrometry Facility (G.A.S.), Faculty of Medicine, University of New South Wales, Randwick, New South Wales 2052, Australia; Department of Pharmacology (C.S.), Innsbruck Medical University, A-6020 Innsbruck, Austria; and Neuroscience Institute of Schizophrenia and Allied Disorders (T.K.), Darlinghurst, Sydney, New South Wales 2010, Australia

Address all correspondence and requests for reprints to: Amanda Sainsbury, Neuroscience Program, Garvan Institute of Medical Research, St. Vincent’s Hospital, 384 Victoria Street, Darlinghurst, Sydney, New South Wales 2010, Australia. E-mail: a.sainsbury-salis{at}garvan.org.au.

Endogenous opioids, particularly dynorphins, have been implicated in regulation of energy balance, but it is not known how they mediate this in vivo. We investigated energy homeostasis in dynorphin knockout mice (Dyn–/– mice) and probed the interactions between dynorphins and the neuropeptide Y (NPY) system. Dyn–/– mice were no different from wild types with regards to body weight and basal and fasting-induced food intake, but fecal output was increased, suggesting decreased nutrient absorption, and they had significantly less white fat and lost more weight during a 24-h fast. The neuroendocrine and thermal responses to fasting were at least as pronounced in Dyn–/– as in wild types, and there was no stimulatory effect of dynorphin knockout on 24-h energy expenditure (kilocalories of heat produced) or physical activity. However, Dyn–/– mice showed increased circulating concentrations of 3,4-dihydroxyphenlacetic acid and 3,4-dihydroxyphenylglycol, suggesting increased activity of the sympathetic nervous system. The respiratory exchange ratio of male but not female Dyn–/– mice was reduced, demonstrating increased fat oxidation. Interestingly, expression of the orexigenic acting NPY in the hypothalamic arcuate nucleus was reduced in Dyn–/– mice. However, fasting-induced increases in pre-prodynorphin expression in the arcuate nucleus, the paraventricular nucleus, and the ventromedial hypothalamus but not the lateral hypothalamus were abolished by deletion of Y1 but not Y2 receptors. Therefore, ablation of dynorphins results in increases in fatty acid oxidation in male mice, reductions in adiposity, and increased weight loss during fasting, possibly via increases in sympathetic activity, decreases in intestinal nutrient absorption, and interactions with the NPYergic system.




This article has been cited by other articles:


Home page
DiabetesHome page
M. A. Mori, R. C. Araujo, F. C.G. Reis, D. G. Sgai, R. G. Fonseca, C. C. Barros, V. F. Merino, M. Passadore, A. M. Barbosa, B. Ferrari, et al.
Kinin B1 Receptor Deficiency Leads to Leptin Hypersensitivity and Resistance to Obesity
Diabetes, June 1, 2008; 57(6): 1491 - 1500.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society